Free Trial
OTCMKTS:DSRLF

DiaSorin (DSRLF) Stock Price, News & Analysis

DiaSorin logo
$109.01 0.00 (0.00%)
As of 05/2/2025

About DiaSorin Stock (OTCMKTS:DSRLF)

Key Stats

Today's Range
$109.01
$109.01
50-Day Range
$100.01
$109.60
52-Week Range
$100.01
$109.60
Volume
N/A
Average Volume
81 shs
Market Capitalization
$5.96 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
Hold

Company Overview

DiaSorin S.p.A. engages in development, manufacture, and distribution of immunodiagnostics and molecular diagnostics testing kits in Europe, Africa, North America, Central and South America, the Asia Pacific, and China. The company provides various immunodiagnostic LIAISON platforms, including LIAISON XS, LIASON IQ, LIAISON XL, LIAISON XXL, and LIAISON XL LAS. It also offers molecular diagnostics platforms comprising of LIAISON NES, a new molecular platform to address the growing diagnostic decentralization trend; the ARIES and ARIES M1 systems; LIAISON MDX, a thermocycler with two consumable disc options; LIAISON MDX Plus; MAGPIX System; Luminex 100/200 System; VERIGENE System; and the LIAISON PLEX System. It has partnership agreements with QIAGEN for diagnostic solution for Latent Tuberculosis detection; TTP for the development of molecular Point-of-Care solution; and MeMed for the launch of a test differentiating between viral and bacterial infections. The company was founded in 1968 and is headquartered in Saluggia, Italy.

Receive DSRLF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for DiaSorin and its competitors with MarketBeat's FREE daily newsletter.

DSRLF Stock News Headlines

DiaSorin: Anticipate A Double-Digit EBITDA Growth Rate
DiaSorin S.p.A. (0GZX) Receives a Hold from Barclays
Silicon Valley Gold Rush
A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bill Gates has backed four companies in this space. The World Economic Forum calls it “the most exciting human discovery since fire.” Whitney Tilson believes this trend could mint a new class of wealthy investors—and he’s sharing one stock to watch now, for free.
DiaSorin S.p.A. (0GZX) Receives a Sell from Kepler Capital
DiaSorin stock rises despite mixed financial results
UBS Remains a Hold on DiaSorin S.p.A. (0GZX)
See More Headlines

DSRLF Stock Analysis - Frequently Asked Questions

DiaSorin's stock was trading at $106.8545 at the beginning of the year. Since then, DSRLF stock has increased by 2.0% and is now trading at $109.01.
View the best growth stocks for 2025 here
.

Shares of DSRLF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Today
5/03/2025
Next Earnings (Estimated)
5/08/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
Private households
Sub-Industry
Misc.
Current Symbol
OTCMKTS:DSRLF
CIK
N/A
Fax
N/A
Employees
3,186
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$1.24 billion
Cash Flow
$9.66 per share
Price / Cash Flow
11.29
Price / Book
N/A

Miscellaneous

Free Float
N/A
Market Cap
$5.96 billion
Optionable
Not Optionable
Beta
0.33
10 Best Cheap Stocks to Buy Now Cover

MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Enter your email address and below to see which companies made the list.

Get This Free Report

This page (OTCMKTS:DSRLF) was last updated on 5/3/2025 by MarketBeat.com Staff
From Our Partners